AI assistant
Sending…
CNS Pharmaceuticals, Inc. — Director's Dealing 2021
Nov 18, 2021
35399_dirs_2021-11-18_87dfe93b-9ccd-4c44-bfa7-b412fd800b60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CNS Pharmaceuticals, Inc. (CNSP)
CIK: 0001729427
Period of Report: 2021-11-16
Reporting Person: Climaco John M (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-16 | Common Stock | A | 5000 | $1.28 | Acquired | 905298 | Direct |
More from CNS Pharmaceuticals, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 2